 The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly, and hair restoration.The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle.The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company.